Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. As of February 23, 2022, the company managed an extensive network of 4,171 outpatient dialysis clinics across roughly 150…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
1D
+0.2%
1W
+5.3%
1M
-3.5%
6M
-5.3%
YTD
-6.9%
1Y
-18.0%
2Y
+10.7%
5Y
-37.5%
10Y
-46.9%
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~69% stronger price swings than usual
PRICE TARGET LOW
US$19.90
CONSENSUS
US$23.67
MEDIAN
US$24.50
PRICE TARGET HIGH
US$25.80
0
STRONG BUY
5
BUY
14
HOLD
2
SELL
0
STRONG SELL
21
TOTAL · Hold
As of: 12/10/2026
P/E
11.91
P/B
0.85
EV/EBITDA
5.75
RETURN ON EQUITY
1.7%
NET MARGIN
4.5%
DEBT/EQUITY
0.87
DIVIDEND YIELD
3.8%
AS OF
30/06/2026
FREE FLOAT
100.0%
FLOAT SHARES
532,207,336
AVG. DAILY VOLUME (30D)
875,245
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +0.2%
Forums (Reddit)
Fresenius Medical Care AG & Co. KGaA is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in Germany.
The CEO is Helen Giza, the company employs around 108,165 people.
The IPO was on 17/09/1996; the stock trades on NYSE under the ticker FMS.
21 analysts rate the stock, the consensus is Hold (as of 12/10/2026).
The average price target is US$23.67, ranging from US$19.90 to US$25.80, with a median of US$24.50.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 69% stronger than usual.
Yes. The last dividend was US$0.86 per share, ex-date 22/05/2026, paid on 08/06/2026.
The dividend yield is 3.8% (as of 30/06/2026).
Comparable stocks include Fresenius, Fresenius Medical Care, HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health and LifeStance Health Group.
Clicking "Analyze stock" lets five strategies assess Fresenius Medical Care against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.